U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07708116) titled 'First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients' on July 13.
Brief Summary: The primary objective of this trial is to assess the safety and tolerability of single and multiple ascending intravenously (IV) infused doses of CTX-187 when administered to healthy adult male and female participants and participants with a bacterial infection (bronchiectasis participants chronically infected with P. aeruginosa).
Study Start Date: June 16
Study Type: INTERVENTIONAL
Condition:
Bronchiectasis Adult
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Bacterial Infections
Intervention:
DRUG: Pla...